SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000053417-07-000029
Filing Date
2007-02-14
Accepted
2007-02-14 10:43:34
Documents
1

Document Format Files

Seq Description Document Type Size
1 VANDA PHARMACEUTICALS 1206 vnda06.txt SC 13G 7144
  Complete submission text file 0000053417-07-000029.txt   8976
Mailing Address 466 LEXINGTON AVE NEW YORK NY 10017
Business Address 466 LEXINGTON AVE NEW YORK NY 10017 2124211000
JENNISON ASSOCIATES LLC (Filed by) CIK: 0000053417 (see all company filings)

IRS No.: 132631108 | State of Incorp.: NY | Fiscal Year End: 1231
Type: SC 13G

Mailing Address 9620 MEDICAL CENTER DR SUITE 201 ROCKVILLE MD 20850
Business Address 9620 MEDICAL CENTER DR SUITE 201 ROCKVILLE MD 20850 301-294-9300
Vanda Pharmaceuticals Inc (Subject) CIK: 0001305597 (see all company filings)

IRS No.: 000000000
Type: SC 13G | Act: 34 | File No.: 005-82603 | Film No.: 07614635